相关实验视频

Updated: Feb 28, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

达成共识临床小组的副本数量改变签名使全癌症风险分层和治疗响应协会能够实现

Adar Yaacov^1,2

¹Helmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.

International journal of molecular sciences

|February 27, 2026

概括

这项研究引入了一个新的框架来分析来自癌症基因组的拷贝数变化 (CNA). 该框架提取CNA签名,为精密瘤学提供有价值的预后和治疗见解.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

身体副本数变化 (CNA) 在癌症中很常见,但很难从向测序面板中分析.
现有的方法为全面的CNA签名分析提供有限的数据.

研究的目的:

开发一个共识框架,整合多个算法,从目标面板数据中提取CNA签名.
在一个大癌症队列中识别和表征可复制的CNA签名.

主要方法:

开发了一个共识框架,结合了四个解卷算法.
应用了框架来分析使用MSK-IMPACT测序的24870个瘤的CNA数据.
通过内部交叉验证和外部队列 (肉瘤,肝细胞癌) 验证识别的签名.

主要成果:

确定了五个可复制的CNA签名 (CON1-CON5),区分近双倍体和无双倍体图案.
签名显示出与瘤类型 (FDR <0.01) 的整体存活率有显著的关联.
签名提供了除了基因组改变的部分之外的预后信息,并与驱动突变和治疗耐药性相关联.

结论:

该框架有效地从常规面板数据中提取生物可解释的CNA签名.
这些特征增强了预后能力,并可指导精密瘤学的治疗决策.
通过将稀疏的面板数据转换为可操作的功能,使风险分层和个性化治疗策略成为可能.

关键词:

生物标志物生物标志物癌症基因组学癌症基因组学副本编号的更改签名的签名解构算法的解构算法精确瘤学精确瘤学

更多相关视频

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Serum and Plasma Copy Number Detection Using Real-time PCR

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

相关概念视频

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...